Looking for volunteers
Evaluation of Wellbeing and Patient Reported Outcomes After Open vs Robotic Mastectomy With DIEP Reconstruction
NCT07230535 · Beaumont Hospital · Updated 1 June 2026
- What is being tested
- Robotic Assisted Nipple Sparing Mastectomy; Standarding Open Nipple Sparing Mastectomy
- For
- Breast Cancer, Breast Neoplasms; Breast Reconstruction; DIEP Flap Breast Reconstruction; Robotic Surgery
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 250 people. The full rules are on the registry page.
- Where
- Ireland
- When
- Starts or started 1 Dec 2025, ends 31 Dec 2029. Registered 17 Nov 2025.
- Results
- None posted yet.
In the researchers' words
Nipple-sparing mastectomy (NSM) preserves the nipple-areolar complex (NAC) and is associated with improved cosmetic outcomes, body image, and patient satisfaction compared with more ablative techniques. Its use has expanded in both therapeutic and risk-reducing settings, including ductal carcinoma in situ (DCIS) and early-stage invasive breast cancer, where the NAC is not clinically or radiologically involved. Multiple observational and cohort studies support the oncological safety of NSM in appropriately selected patients, provided meticulous surgical technique and pathological assessment are employed to minimise the risk of residual disease. Robotic-assisted NSM has emerged as a minimally invasive alternative to conventional open techniques. Robotic platforms offer enhanced three-dimensional visualisation, improved instrument articulation, and ergonomic advantages that may facilitate precise dissection while reducing surgeon fatigue. Single-port robotic systems enable NSM to be performed through a single axillary incision, potentially reducing visible scarring and postoperative discomfort while maintaining oncological principles. Early series from high-volume centres have demonstrated the technical feasibility and short-term safety of robotic NSM, with outcomes broadly comparable to open NSM and signals of potential aesthetic benefit. However, these data are largely…
Sites
- Beaumont RCSI Cancer CentreBeaumont, Ireland
